Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Clinical trial NCT04492787 · COMPLETED
Trial details
- NCT number
- NCT04492787
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2022-04-21
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.